A. A. Kadhim, M. Y. Jamal, and A. K. Karim, “Natalizumab Immunogenicity in Multiple Sclerosis: Evaluating Antibody Development and Clinical Outcomes in an Iraqi Cohort”, Al-Rafidain J Med Sci, vol. 9, no. 2, pp. 83–89, Oct. 2025.